Sino Biopharmaceutical Ltd Stock Analysis
SBHMY Stock | USD 9.05 0.00 0.00% |
Sino Biopharmaceutical Ltd is overvalued with Real Value of 7.49 and Hype Value of 9.05. The main objective of Sino Biopharmaceutica pink sheet analysis is to determine its intrinsic value, which is an estimate of what Sino Biopharmaceutical Ltd is worth, separate from its market price. There are two main types of Sino Biopharmaceutica's stock analysis: fundamental analysis and technical analysis.
The Sino Biopharmaceutica pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Sino |
Sino Pink Sheet Analysis Notes
The book value of the company was at this time reported as 32.7. The company has Price/Earnings To Growth (PEG) ratio of 0.53. Sino Biopharmaceutical last dividend was issued on the 6th of September 2022. The entity had 1:1 split on the 14th of August 2020. Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the Peoples Republic of China. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong. Sino Biopharmaceutica is traded on OTC Exchange in the United States.The quote for Sino Biopharmaceutical Ltd is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Sino Biopharmaceutical Ltd contact Ping Tse at 852 2802 9886 or learn more at https://www.sinobiopharm.com.Sino Market Capitalization
The company currently falls under 'Large-Cap' category with a current market capitalization of 10.88 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sino Biopharmaceutica's market, we take the total number of its shares issued and multiply it by Sino Biopharmaceutica's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Sino Profitablity
The company has Profit Margin (PM) of 0.29 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.16 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.16.Technical Drivers
As of the 27th of November, Sino Biopharmaceutica has the Variance of 8.17, risk adjusted performance of 0.107, and Coefficient Of Variation of 766.78. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sino Biopharmaceutical, as well as the relationship between them.Sino Biopharmaceutical Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Sino Biopharmaceutica middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Sino Biopharmaceutical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Sino Biopharmaceutica Outstanding Bonds
Sino Biopharmaceutica issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Sino Biopharmaceutical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Sino bonds can be classified according to their maturity, which is the date when Sino Biopharmaceutical Ltd has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Boeing Co 2196 Corp BondUS097023DG73 | View | |
HSBC Holdings PLC Corp BondUS404280DR76 | View | |
MGM Resorts International Corp BondUS552953CD18 | View | |
AerCap Global Aviation Corp BondUS00773HAA59 | View |
Sino Biopharmaceutica Predictive Daily Indicators
Sino Biopharmaceutica intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Sino Biopharmaceutica pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Sino Biopharmaceutica Forecast Models
Sino Biopharmaceutica's time-series forecasting models are one of many Sino Biopharmaceutica's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Sino Biopharmaceutica's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Sino Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Sino Biopharmaceutica prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Sino shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Sino Biopharmaceutica. By using and applying Sino Pink Sheet analysis, traders can create a robust methodology for identifying Sino entry and exit points for their positions.
Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the Peoples Republic of China. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong. Sino Biopharmaceutica is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Sino Biopharmaceutica to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Watchlist Optimization Now
Watchlist OptimizationOptimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
All Next | Launch Module |
Additional Tools for Sino Pink Sheet Analysis
When running Sino Biopharmaceutica's price analysis, check to measure Sino Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sino Biopharmaceutica is operating at the current time. Most of Sino Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of Sino Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sino Biopharmaceutica's price. Additionally, you may evaluate how the addition of Sino Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.